Cargando…
A Review of the Clinical Trial Landscape in Psoriasis: An Update for Clinicians
As our understanding of the pathogenesis of psoriasis has evolved over the past two decades, so has the number of treatment options. The introduction of biologic agents targeting specific cytokines in the interleukin (IL)-23/IL-17 pathway has proven successful in promoting skin clearance among patie...
Autores principales: | Drakos, Anastasia, Vender, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674811/ https://www.ncbi.nlm.nih.gov/pubmed/36319883 http://dx.doi.org/10.1007/s13555-022-00840-9 |
Ejemplares similares
-
Biologic Treatments of Psoriasis: An Update for the Clinician
por: Brownstone, Nicholas D, et al.
Publicado: (2021) -
Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?
por: Metko, Dea, et al.
Publicado: (2023) -
Systemic Role for Vitamin D in the Treatment of Psoriasis and Metabolic Syndrome
por: Fu, Lisa Wenyang, et al.
Publicado: (2011) -
Plaque psoriasis and morphea in a patient on ustekinumab: A case report
por: Cirone, Katrina, et al.
Publicado: (2023) -
Comorbidity in Adult Psoriasis: Considerations for the Clinician
por: Daugaard, Christine, et al.
Publicado: (2022)